AIkido Pharma Inc (USD)
AIKI
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.80 | 0.84
52-Wk Range- | -
Last Close0.84
Mkt Cap (m)29.25
Dividend yield-
ISINUS0088751062
Volume1,330,955.00
Exchange VenueNAS

Company Profile

Spherix Inc is a patent commercialization company whose operations are focused on the monetization of its intellectual property.

Key Information
Price/Earning-
Price/Book1.39
Price/Sales-
P/CF-
Rev Growth (3 year avg)-78.27
EPS Growth (3 year avg)-
Operating Margin % -63,166.67
Net Margin %-46,477.78
Return on Equity-36.97
Debt/Equity-

Documents

Prospectus
en 15/04/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.spherix.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)0.010.030.881.240.030.01
Operating Income (m)-30.61-11.41-5.84-3.82-4.47-5.69
Net Income (m)-30.53-51.47-6.48-3.311.73-4.18
Basic EPS-125.16-106.1728.73-2.550.89-1.67
Avg. Diluted Shares Outstanding (m)0.240.400.901.301.902.51
Balance Sheet
USD201420152016201720182019
Current Assets (m)4.413.866.294.352.911.13
Non Current Assets (m)56.759.834.984.6310.3510.15
Total Assets (m)61.1613.6911.288.9713.2511.28
Current Liabilities (m)1.234.462.672.581.150.75
Total Liabilities (m)------
Total Equity (m)53.598.755.324.1112.1010.53
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-9.52-4.620.07-3.27-2.73-3.02
Capital Expenditure (m)-1.000.000.00--0.04-0.36
Figures are quoted in USD unless stated otherwise
-0.02 (-2.46%)
$
0.82
Last Price